An interaction between warfarin and cannabidiol, a case report
Epilepsy & Behavior Case Reports · 2018 · 9 · 10-11
DOI: 10.1016/j.ebcr.2017.10.001 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epilepsy & Behavior Case Reports, 2018. Verfasst von Leslie Grayson und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama at Birmingham, United States. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
•An interaction between warfarin and cannabidiol is described•The mechanisms of cannabidiol and warfarin metabolism are reviewed•Mechanism of the interaction is proposed•INR should be monitored in patients when cannabinoids are introduced.
Autor:innen und Institutionen
- University of Alabama at Birmingham, United States.
- Greenwich Biosciences, United States.
Zitieren
APA
Grayson, L., Vines, B., Nichol, K., Szaflarski, J. P., & UAB CBD Program (2018). An interaction between warfarin and cannabidiol, a case report. Epilepsy & Behavior Case Reports, 9, 10-11. https://doi.org/10.1016/j.ebcr.2017.10.001
Vancouver
Grayson L, Vines B, Nichol K, Szaflarski JP, UAB CBD Program. An interaction between warfarin and cannabidiol, a case report. Epilepsy & Behavior Case Reports. 2018;9:10-11. doi:10.1016/j.ebcr.2017.10.001
BibTeX
@article{Grayson2018,
author = {Grayson, Leslie and Vines, Brannon and Nichol, Kate and Szaflarski, Jerzy P and UAB CBD Program, UAB CBD Program},
title = {An interaction between warfarin and cannabidiol, a case report},
journal = {Epilepsy & Behavior Case Reports},
year = {2018},
volume = {9},
pages = {10--11},
doi = {10.1016/j.ebcr.2017.10.001}
}
EUVIMED